These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36376772)

  • 21. Liver transplantation for primary sclerosing cholangitis.
    Gow PJ; Chapman RW
    Liver; 2000 Apr; 20(2):97-103. PubMed ID: 10847476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
    Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
    Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver transplantation for primary sclerosing cholangitis.
    Solano E; Khakhar A; Bloch M; Quan D; McAlister V; Ghent C; Wall W; Marotta P
    Transplant Proc; 2003 Nov; 35(7):2431-4. PubMed ID: 14611979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.
    Haruki K; Shiba H; Shimada J; Okui N; Iida T; Yanaga K
    Clin J Gastroenterol; 2017 Feb; 10(1):47-51. PubMed ID: 27796825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
    Brandsaeter B; Schrumpf E; Bentdal O; Brabrand K; Smith HJ; Abildgaard A; Clausen OP; Bjoro K
    Liver Transpl; 2005 Nov; 11(11):1361-9. PubMed ID: 16184522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
    Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
    Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis.
    Onofrio F; Zheng K; Xu C; Chen S; Xu W; Vyas M; Bingham K; Patel K; Lilly L; Cattral M; Selzner N; Jaeckel E; Tsien C; Gulamhusein A; Hirschfield GM; Bhat M
    Hepatol Commun; 2023 Aug; 7(8):. PubMed ID: 37534935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation.
    Esfeh JM; Eghtesad B; Hodgkinson P; Diago T; Fujiki M; Hashimoto K; Quintini C; Aucejo F; Kelly D; Winans C; Vogt D; Miller C; Zein N; Fung J
    HPB (Oxford); 2011 Sep; 13(9):651-5. PubMed ID: 21843266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
    Hildebrand T; Pannicke N; Dechene A; Gotthardt DN; Kirchner G; Reiter FP; Sterneck M; Herzer K; Lenzen H; Rupp C; Barg-Hock H; de Leuw P; Teufel A; Zimmer V; Lammert F; Sarrazin C; Spengler U; Rust C; Manns MP; Strassburg CP; Schramm C; Weismüller TJ;
    Liver Transpl; 2016 Jan; 22(1):42-52. PubMed ID: 26438008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living donor liver transplantation in children with cholestatic liver disease: a single-center experience.
    Mizuta K; Urahashi T; Ihara Y; Sanada Y; Wakiya T; Yamada N; Okada N; Egami S; Hishikawa S; Hyodo M; Sakuma Y; Fujiwara T; Kawarasaki H; Yasuda Y
    Transplant Proc; 2012 Mar; 44(2):469-72. PubMed ID: 22410047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
    Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study.
    Tan N; Ngu N; Worland T; Lee T; Abrahams T; Pandya K; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson A; Ding J; Nicoll AJ; Liu K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A;
    Hepatol Int; 2022 Oct; 16(5):1094-1104. PubMed ID: 35657479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis.
    Martin EF; Levy C
    Semin Liver Dis; 2017 Nov; 37(4):305-313. PubMed ID: 29272893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roux-en-Y choledochojejunostomy versus duct-to-duct biliary anastomosis in liver transplantation for primary sclerosing cholangitis: a meta-analysis.
    Wells MM; Croome KP; Boyce E; Chandok N
    Transplant Proc; 2013; 45(6):2263-71. PubMed ID: 23953538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center.
    Astarcioglu I; Egeli T; Unek T; Akarsu M; Sagol O; Obuz F; Ozbilgin M; Aysal Agalar A; Ağalar C
    Exp Clin Transplant; 2018 Aug; 16(4):434-438. PubMed ID: 30060730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
    Henson JB; Patel YA; Wilder JM; Zheng J; Chow SC; King LY; Muir AJ
    Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
    Ravikumar R; Tsochatzis E; Jose S; Allison M; Athale A; Creamer F; Gunson B; Iyer V; Madanur M; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A
    J Hepatol; 2015 Nov; 63(5):1139-46. PubMed ID: 26186988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
    Tanaka A; Kono H; Leung PSC; Gershwin ME
    Cell Immunol; 2020 Jan; 347():104021. PubMed ID: 31767117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of primary sclerosing cholangitis in patients after liver transplantation.
    Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L
    Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis.
    Varotti G; Gondolesi GE; Roayaie S; Suriawinata A; Soltys K; Fishbein TM; Schwartz ME; Miller C
    J Am Coll Surg; 2003 Nov; 197(5):765-9. PubMed ID: 14585411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.